Founded in 2001 with the goal of developing innovative antibody-based therapeutics to treat cancer.
Our pipeline also includes rare disease therapeutics, in addition to the anti-cancer therapeutics that we developed on our way to becoming a leading biotechnology company in Korea. By providing new ways of combatting cancer and rare diseases, ISU ABXIS will fulfill its vision of enhancing the liv...